Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-001495
Filing Date
2018-01-09
Accepted
2018-01-09 17:02:20
Documents
1
Period of Report
2018-01-05

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3830
  Complete submission text file 0001104659-18-001495.txt   5418
Mailing Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 2012 NEW YORK NY 10170 212-297-0020
SYNERGY PHARMACEUTICALS, INC. (Issuer) CIK: 0001347613 (see all company filings)

EIN.: 330505269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O IASO PHARMA INC. 12707 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130
Business Address
Gemignani Gary G (Reporting) CIK: 0001512256 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35268 | Film No.: 18519665